The human mast cell line HMC-1 binds and responds to C3a but not C3a(desArg)

Scandinavian Journal of Immunology

Volumn 47, Issue 1, 1998, Pages 19-24

  Zwirner, J ^a   Gotze O ^a   Sieber, A ^b   Kapp, A ^b   Begemann, G ^b   Zuberbier, T ^c   Werfel, T ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C3A;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CALCIUM CELL LEVEL; CELL TYPE; CHEMOTAXIS; DRUG RECEPTOR BINDING; FLOW CYTOMETRY; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MAST CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY; THROMBOCYTE AGGREGATION;

ANIMALS; CALCIUM; CELL LINE; COMPLEMENT C3A; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MACROPHAGE-1 ANTIGEN; MAST CELLS; MICE; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0031964364     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00250.x     Document Type: Article

References (32)

1. Becker S, Meuer S, Hadding U, Bitter-Suermann D. Platelet activation: a new biological activity of guinea-pig C3a anaphylatoxin. Scand J Immunol 1978;7:173-80.
2. Elsner J, Oppermann M, Czech W et al. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur J Immunol 1994;24:518-22.
3. Takafuji S, Tadokoro K, Dahinden CA. Degranulation from human eosinophils stimulated with C3a and C5a. Int Arch Allergy Appl Immunol 1994;104:27-9.
4. Daffern PJ, Pfeifer PH, Ember JA, Hugli TE. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 1995;181:2119-27.
5. Bischoff SC, de Weck AL, Dahinden CA. Interleukin 3 and granulocyte/ macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc Natl Acad Sci USA 1990;87:6813-7.
6. El-Lati SG, Dahinden CA, Church MK. Complement peptides C3a-and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 1994;102:803-6.
7. Kretschmar T, Jeromin A, Gietz C et al. Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a. Eur J Immunol 1993; 23:558-61.
8. Mousli M, Hugli TE, Landry Y, Bronner C. A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J Immunol 1992;148:2456-61.
9. Haeffner-Cavaillon N, Cavaillon JM, Laude M, Kazatchkine MD. C3a (C3a des-Arg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol 1987;139:794-9.
10. Takabayashi T, Vannier E, Clark BD et al. A new biologic role for C3a and C3a desArg. J Immunol 1996;156:3455-60.
11. Morgan EL. The role of prostaglandins in C3a-mediated suppression of human in vitro polyclonal antibody responses. Clin Immunol Immunopathol 1987;44:1-11.
12. Nilsson G, Johnell M, Hammer CH et al. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 1996;157:1693-8.
13. Legler DF, Loetscher M, Jones SA, Dahinden CA, Arock M, Moser B. Expression of high- and low-affinity receptors for C3a on the human mast cell line HMC-1. Eur J Immunol 1996;26:753-8.
14. Ames RS, Li Y, Sarau HM et al. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Chem 1996;271:20231-4.
15. Crass T, Raffetseder U, Martin U et al. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells. Eur J Immunol 1996;26:1944-50.
16. Püschel GP, Oppermann M, Muschol W, Götze O, Jungermann K. Increase of glucose and lactate output and decrease of flow by human anaphylatoxin C3a but not C5a in perfused rat liver. FEBS Lett 1989;243:83-7.
17. De Bruijan MH, Fey GH. Human complement component C3: cDNA coding sequence and derived primary structure. Proc Natl Acad Sci USA 1985;82:708-12.
18. Rothermel E, Rolf O, Götze O, Zwirner J. Nucleotide and corrected amino acid sequence of the functional recombinant rat anaphylatoxin C5a. Biochim Biophys Acta 1997;1351:9-12.
19. 125J-C3a binding. Biochemistry 1992;31:11274-82.
20. Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988;12:345-55.
21. Elsner J, Kaever V, Emmendörffer T, Breidenbach M-L, Lohmann-Mathes R, Roesler J. Heterogeneity in the mobilization of cytoplasmic calcium by human polymorphonuclear leukocytes in response to fMLP, C5a and IL-8/NAP-1. J Leukocyte Biol 1992;51:77-83.
22. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 1985;82:6133-7.
23. Schwartz L, Huft T. Biology of mast cells and basophils. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy. Principles and Practice, 4th edn. St Louis: Mosby, 1993:135-68.
24. Nilsson G, Blom T, Kusche-Gullberg M et al. Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol 1994;39:489-98.
25. Werfel T, Oppermann M, Butterfield JH et al. The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a (desArg). Scand J Immunol 1996;44:30-6.
26. Füreder W, Agis H, Willheim M et al. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J Immunol 1995;155:3152-60.
27. + cells and react with a desmosomal antigen in human skin. J Immunol 1996;157: 1729-35.
28. Arend WP, Massoni RJ, Niemann MA, Ciclas PC. Absence of induction of IL-1 production in human monocytes by complement fragments. J Immunol 1989;142:173-8.
29. Fukuoku Y, Hugli TE. Anaphylatoxin binding and degradation by rat peritoneal mast cells. J Immunol 1990;145:1855-8.
30. Bokisch VA, Müller-Eberhardt HJ. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest 1970;49:2427-36.
31. Lu ZX, Fox KF, Erickson BW, Hugli TE. Conformational analysis of COOH-terminal segments of human C3a. Evidence of ordered conformation in an active 21-residue peplide. J Biol Chem 1984; 259:7367-72.
32. Fukuoka Y, Tachibana T, Yasui A. Expression of biologically active C3a as fusion proteins. Immunology Lett 1993;38:153-8.